WHARTEXA 60B HUC-MSCs Exosome
Whartexa 60B HUC-MSCs Exosome is the flagship ultra high-concentration regenerative extracellular vesicle formulation developed by Nanoventra under the proprietary Whartexa Line.
Derived from carefully processed Wharton’s Jelly Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs), this premium exosome platform is engineered through precision extracellular vesicle isolation technologies, advanced purification workflows, and controlled cryopreservation methodologies intended to support maximum vesicle integrity, biological consistency, and advanced regenerative signaling performance.
Human-Derived Exosomes From:*
Wharton’s Jelly
Product image shown represents the finalized Whartexa formulation. Actual presentation may vary slightly depending on packaging updates, preservation configuration, and production optimization protocols.
Details
Quality
Related Products
Details
WHARTEXA 60B HUC-MSCs Exosome
Nanoventra develops advanced HUC-MSC-derived extracellular vesicle systems through controlled purification technologies, laboratory-grade extracellular vesicle isolation methodologies, and precision cryopreservation workflows designed to maintain extracellular vesicle integrity, biological stability, and regenerative signaling consistency.
​
Whartexa 60B is formulated from carefully processed Wharton’s Jelly umbilical biological sources and represents the highest concentration formulation within the proprietary Whartexa regenerative biotechnology platform.
​
This formulation is optimized for professional regenerative integration environments requiring maximum extracellular vesicle concentration systems, precision nano-vesicle preservation technologies, advanced biological consistency support, and biotechnology-oriented formulation standards.
​
Human umbilical cord-derived extracellular vesicles continue to gain scientific recognition within regenerative biotechnology, extracellular signaling research, advanced dermatological integration science, scalp-focused regenerative systems, and next-generation regenerative medicine development platforms.
Whartexa 60B reflects Nanoventra’s premium biotechnology engineering approach toward advanced extracellular vesicle refinement, high-concentration regenerative platform development, and controlled exosome preservation systems.
Key Features
-
Proprietary Whartexa regenerative exosome platform
-
Human Wharton’s Jelly HUC-MSC-derived extracellular vesicles
-
60 Billion particle concentration system
-
Flagship ultra high-concentration regenerative formulation
-
Advanced extracellular vesicle purification workflows
-
Controlled laboratory-grade isolation methodologies
-
Cryopreserved formulation maintained at −20°C
-
Enhanced vesicle stability and biological consistency
-
Professional regenerative and biotechnology-oriented integration
-
Advanced nano-vesicle handling and preservation systems
-
Research-focused extracellular vesicle preparation protocols
Quality
Specifications
All Whartexa 60B HUC-MSCs Exosome formulations undergo advanced scientific quality verification through multi-stage extracellular vesicle processing systems, laboratory-oriented preparation workflows, and precision purification methodologies.
​
Each preparation is processed under sterile laboratory-grade conditions with focused attention toward:
-
extracellular vesicle integrity
-
particle concentration consistency
-
biological stability
-
purification precision
-
advanced handling reproducibility
​
Nanoventra applies biotechnology-oriented quality methodologies intended to support formulation consistency across regenerative extracellular vesicle systems and advanced exosome engineering platforms.
​
The Whartexa Line represents Nanoventra’s flagship regenerative biotechnology division focused on advanced extracellular vesicle refinement, precision biological preservation systems, and controlled exosome formulation development.
Storage & Handling
-
Recommended storage temperature: −20°C
-
Maintain cryopreserved conditions during handling
-
Avoid repeated freeze-thaw exposure
-
Professional laboratory-oriented handling recommended